FN1 and neoplasm: Plasma serine protease inhibitor (SERPINA5), mainly synthesized in the liver, is a multifunctional tumor suppressor that reduces the metastatic property of hepatic cancer cell lines by disrupting the fibronectin–integrin signaling pathway [23–25].